Ovarian cysts in women receiving tamoxifen for breast cancer
1999

Ovarian Cysts in Women Taking Tamoxifen for Breast Cancer

Sample size: 142 publication Evidence: moderate

Author Information

Author(s): Mourits M J E, Vries E G E de, Willemse P H B, Hoor K A ten, Hollema H, Sluiter W J, Bruijn H W A de

Primary Institution: University Hospital Groningen

Hypothesis

The study aimed to evaluate patient-related parameters that determine ovarian cyst formation in women using tamoxifen for breast cancer.

Conclusion

Breast cancer patients receiving tamoxifen only develop ovarian cysts if their ovaries can respond to FSH stimulation.

Supporting Evidence

  • 24 tamoxifen-using patients developed uni- or bilateral ovarian cysts.
  • Patients with ovarian cysts had higher serum E2 levels compared to those without.
  • Younger patients and those without high-dose chemotherapy were more likely to develop cysts.

Takeaway

Women taking a medicine called tamoxifen for breast cancer can develop cysts on their ovaries, especially if they are younger and their bodies can still make certain hormones.

Methodology

A cross-sectional study with gynaecological assessments, transvaginal ultrasonography, and hormone level analysis.

Participant Demographics

Breast cancer patients using tamoxifen, with some examined prior to treatment.

Statistical Information

P-Value

P < 0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690280

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication